Minh Quan Vu, M.D., FRCSC

*** * ***** ***** ***, Apt 2J

Jackson, Michigan

49201

phone: 929-***-****

email: adyxr6@r.postjobfree.com

Education

****/**-

current Henry Ford Health (Jackson)

Cardiac Surgeon

2021/09/01-

2022/08/31 Robotic and Minimally Invasive; Clinical Associate

Department of Thoracic and Cardiovascular Surgery at the Cleveland Clinic, Cleveland (OH)

2020/07/01-

2021/06/30 Advanced Coronary Surgery Fellowship (PGY-7)

Mount Sinai Hospital, New York City (NY)

2014/7/01-

2020/10/23 Master degree (MSc), Biomedical Sciences Program, Basic Sciences Profile

Université de Montréal, Faculty of Medicine

2014/7/01-

2020/09/01 Clinician Investigator Program (CIP)

Université de Montréal, Faculty of Medicine

2012/7/01-

2020/06/30 Cardiac Surgery Residency (FRCSC)

Université de Montréal, Faculty of Medicine

2007/9/01

– 2012/6/30 Medicine Doctorate (MD)

Université de Montréal, Faculty of Medecine

2005/09/01

– 2007/5/31 Diploma of College Studies (DEC), Health Science Program

Collège de Bois-de-Boulogne

Credentials

2021/07– Ohio State full clinical license

2020/04– New York State full clinical license

2020/10 Board certification from the Royal College of Canada

Fellow of the Royal College of Surgeons of Canafa (F.R.S.C.S) in Cardiac Surgery

2020/06/30 Postgraduate Medical Training Licence, College of Physicians of Quebec

2019/09/15 USMLE Part 1, Part 2 CK, Part 2 CS, USMLE Part 3– Completed

2012/06/30 LMCC Part 1 & 2 – Completed, Medical Council of Canada

Honours and Awards

2016/10 Best Trainee Presentation Award – 5th Annual Till & McCulloch Stem Cell Network Meeting (1,500 CAD)

2015/9 Entrance Scholarship – MSc Program of Biomedical Sciences, Faculty of Medicine Université de Montréal (7,000 CAD)

2015/10 Best Podium Presentation of the Cardiovascular Research Axis – 7th Annual Meeting of the Quebec Cell, Tissue and Gene Therapy Network

2014/12 Best MSc Candidate Presentation – Annual Clinician Investigator Program Scientific Meeting, Faculty of Medicine, Université de Montréal

Areas of Research

Fundamental Sciences, Experimental Medicine

Current MSc thesis work

Endothelial preservation with the use of Celastrol, a pharmacological extract compound

Supervisors: (1) Dr. Nicolas Noiseux, (2) Dr. Louis P. Perrault

Affiliated Centers: (1) Centre Hospital de l’Université de Montréal, (2) Montreal Heart Institute

Prior research experience

Optimizing stem cell therapy in cardiovascular disease application

Supervisors: Dr. Nicolas Noiseux and Dr. Shant DerSakissian

Affiliated Center: Centre Hospital de l’Université de Montréal

Publications

Articles

M. Vu, S. Der Sarkissian, N. Noiseux, M. Borie, S. Mansour, L. Stevens. Novel pharmacological approach to vein graft failure prevention. Canadian Journal of Cardiology. Vol.32, Issue 10, S228. October 2016.

H. Aceros, S. Der Sarkissian, M. Vu, N. Noiseux, M. Borie, S. Mansour, L. Stevens. Celastrol protects against ischemia/reperfusion-induced cardiac cell death. Canadian Journal of Cardiology. Vol.31, Issue 10, S4. October 2015.

Noiseux N, Mansour S, Weisel R, Stevens LM, Der Sakissian S, Tsang K, Crean AM, Larose E, Li SH, Wintersperger B, Vu M Q, Prieto I, Li RK, Roy DC, Yau TM. The IMPACT-CABG Trial: A multicenter randomized clinical trial of CD133+ Stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2016 Dec;152(6):1582-1588.e2.

Bégin P, Vu M Q, Picard M, Paradis L, Des Roches A. Spontaneous resolution of diphtheria-tetanus vaccine hypersensitivity in a pediatric population. Allergy. 2011 Nov;66(11):1508-10

Book Chapters

Vu M Q, Der Sarkissian S, Borie M, Bessette PO, Noiseux N. Chapter 16: Optimization of Mesenchymal Stem Cells to Increase their therapeutic potential. Methods in Molecular Biology: Mesenchymal Stem Cells. 2016; 1416:275-88.

Vu M Q, PE Noly, Louis P Perrault. Chapter 28: Preservation solutions and external stents for vein grafts. Coronary Bypass Grafting Surgery. 2019.

Balaram S, Vu M Q. Chapter : Surgical Pulmonary Embolectomy. Pulmonary Embolism. Under review.

Presentations

2019/10 Use of Donor Hearts with Marginal Systolic Function for transplantation: a case matched clinical study

2019 Canadian Cardiovascular Congress, Montreal

2019/12 PCI after OPCAB: does it matter?

International Coronary Congress, New York City

2016/10 (Podium) Optimizing regenerative therapies: Celastrol as a potential molecule for stem cell conditioning. 5th Annual Till & McCulloch Stem Cell Network Meeting, Whistler, Canada

2015/11 (Poster) New conditioning agent for improvement of activity and survival of stem cells during hypoxic and oxidative stress. 15th Annual Convention of the Quebec Society of Vascular Sciences, Quebec City, Canada

2015/10 (Poster) A novel conditioning agent stimulates stem cells activity and viability to hypoxic and oxidative stresses. 2015 Canadian Cardiovascular Congress, Toronto, Canada.

2014/10 (Poster) Preconditioning human stem cells with oxytocin to optimize cell therapy for the treatment of cardiovascular disease. 2014 Canadian Cardiovascular Congress, Vancouver, Canada

Other Academic Activities

2018/8 – 2018/10 Problem-based medical education teacher, cardiology and cardiac sciences block, MD Program, Faculty of Medicine, Université de Montréal

Event Administration Activities

2016/11 – 2019/10 Abstract Reviewer, Canadian Cardiovascular Congress

2015/11 – 2016/10 Organizing Committee Member, Annual Trainee Day at the Canadian Cardiovascular

Congress 2015

Contact this candidate